{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:19Z","timestamp":1792784899443,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001184","name":"Cure Cancer Australia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001184","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AMP Foundation","id":[{"id":"https:\/\/ror.org\/034r39281","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Avner Pancreatic Cancer Foundation","id":[{"id":"https:\/\/ror.org\/0547s4y81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"PdCCRS"},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001184","name":"Cure Cancer Australia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bbadis.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:43:07Z","timestamp":1549885387000},"page":"1361-1378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1"],"prefix":"10.1016","volume":"1865","author":[{"given":"Sumit","family":"Sahni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaklina","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Des R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2019.02.008_bb0005","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/carcin\/bgl146","article-title":"The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer","volume":"27","author":"Kovacevic","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0010","first-page":"1","article-title":"Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy","volume":"1845","author":"Fang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0015","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1074\/jbc.M112.350470","article-title":"The iron chelators Dp44mT and DFO inhibit TGF-beta-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1)","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0020","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1074\/jbc.M115.689653","article-title":"The metastasis suppressor, N-MYC downstream-regulated gene-1 (NDRG1), down-regulates the ErbB family of receptors to inhibit downstream oncogenic signaling pathways","volume":"291","author":"Kovacevic","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0025","doi-asserted-by":"crossref","first-page":"41413","DOI":"10.1074\/jbc.M111.287052","article-title":"Nitric oxide suppresses tumor cell migration through N-Myc downstream-regulated gene-1 (NDRG1) expression: role of chelatable iron","volume":"286","author":"Hickok","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/emmm.201100190","article-title":"N-myc downstream regulated gene 1 modulates Wnt-beta-catenin signalling and pleiotropically suppresses metastasis","volume":"4","author":"Liu","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0035","first-page":"1731","article-title":"The Drg-1 gene suppresses tumor metastasis in prostate cancer","volume":"63","author":"Bandyopadhyay","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/mol.112.083097","article-title":"Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1\/pMLC2 signaling pathway","volume":"83","author":"Sun","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1124\/mol.115.103044","article-title":"Targeting the metastasis suppressor, N-myc downstream regulated gene-1, with novel di-2-pyridylketone thiosemicarbazones: suppression of tumor cell migration and cell-collagen adhesion by inhibiting focal adhesion kinase\/paxillin signaling","volume":"89","author":"Wangpu","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0050","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.18632\/oncotarget.3316","article-title":"The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0055","first-page":"4439","article-title":"Inhibition of tumor cell growth by RTP\/rit42 and its responsiveness to p53 and DNA damage","volume":"58","author":"Kurdistani","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0060","doi-asserted-by":"crossref","first-page":"29659","DOI":"10.1074\/jbc.271.47.29659","article-title":"Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78\/BiP and novel genes","volume":"271","author":"Kokame","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0065","first-page":"85","article-title":"A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms","volume":"77","author":"van Belzen","year":"1997","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1017934810825","article-title":"Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family","volume":"229","author":"Qu","year":"2002","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0075","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.bbadis.2018.04.011","article-title":"Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1","volume":"1864","author":"Park","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/BJ20041057","article-title":"Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3","volume":"384","author":"Murray","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2015.02.090","article-title":"SUMO modification regulates the protein stability of NDRG1","volume":"459","author":"Lee","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130042","article-title":"Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells","volume":"33","author":"Ghalayini","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0095","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1038\/ncomms9698","article-title":"Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2","volume":"6","author":"Oh","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molcel.2014.09.023","article-title":"SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer","volume":"56","author":"Gasser","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2010.04.100","article-title":"Identification of sites subjected to serine\/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)\/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells","volume":"396","author":"Murakami","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0110","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","article-title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation","volume":"104","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057273","article-title":"N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion","volume":"8","author":"Lane","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2156-5-27","article-title":"Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers","volume":"5","author":"Cangul","year":"2004","journal-title":"BMC Genet."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0130","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0135","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/mol.111.073627","article-title":"Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer","volume":"80","author":"Kovacevic","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0145","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1021\/jm300768u","article-title":"Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo","volume":"55","author":"Lovejoy","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0150","first-page":"5370","article-title":"The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo","volume":"8","author":"Li","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"8","key":"10.1016\/j.bbadis.2019.02.008_bb0155","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/ars.2017.7487","article-title":"Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development","volume":"30","author":"Petra","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0160","first-page":"1","article-title":"Exploiting Cancer metal metabolism using anti-cancer metal-binding agents","volume":"25","author":"Merlot","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0165","article-title":"The metastasis suppressor, NDRG1, attenuates oncogenic TGF-beta and NF-kB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells","author":"Menezes","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.phrs.2015.08.013","article-title":"The renaissance of polypharmacology in the development of anti-cancer therapeutics: inhibition of the \u201ctriad of death\u201d in cancer by di-2-pyridylketone thiosemicarbazones","volume":"100","author":"Jansson","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0175","first-page":"250","article-title":"Detection and treatment of mycoplasma contamination in cultured cells","volume":"26","author":"Jung","year":"2003","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0180","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity","volume":"49","author":"Richardson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0185","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-08-1751","article-title":"Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0195","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1074\/jbc.M113.529511","article-title":"The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cells","volume":"289","author":"Sahni","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0200","doi-asserted-by":"crossref","first-page":"G524","DOI":"10.1152\/ajpgi.00138.2017","article-title":"Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges","volume":"313","author":"Maertin","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0205","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.bbamcr.2016.09.011","article-title":"The anticancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), up-regulates the AMPK-dependent energy homeostasis pathway in cancer cells","volume":"1863","author":"Krishan","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0210","doi-asserted-by":"crossref","first-page":"35953","DOI":"10.1074\/jbc.M114.598649","volume":"289","author":"Caohuy","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12964-018-0278-2","article-title":"Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration","volume":"16","author":"Razmara","year":"2018","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0220","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI96477","article-title":"SGK1 induces vascular smooth muscle cell calcification through NF-kappaB signaling","volume":"128","author":"Voelkl","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0225","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1089\/ars.2011.4273","article-title":"The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways","volume":"18","author":"Kovacevic","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0230","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1074\/jbc.275.2.992","article-title":"Distinct classes of phosphatidylinositol 3\u2032-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells","volume":"275","author":"Petiot","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0235","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","article-title":"Proteasome inhibitors: from research tools to drug candidates","volume":"8","author":"Kisselev","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0245","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1074\/jbc.272.14.9086","article-title":"Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance","volume":"272","author":"Bush","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0250","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.STR.0000227259.15506.24","article-title":"Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats","volume":"37","author":"Tsubokawa","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0255","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3892\/or.2017.5355","article-title":"Downregulation of the N-myc downstream regulated gene 1 is related to enhanced proliferation, invasion and migration of pancreatic cancer","volume":"37","author":"Cen","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-4598-13-73","article-title":"PSMD9 expression predicts radiotherapy response in breast cancer","volume":"13","author":"Langlands","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0265","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1074\/jbc.M115.705814","article-title":"The ubiquitin ligases c-Cbl and Cbl-b negatively regulate platelet-derived growth factor (PDGF) BB-induced chemotaxis by affecting PDGF receptor beta (PDGFRbeta) internalization and signaling","volume":"291","author":"Rorsman","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0270","first-page":"3116","article-title":"The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of \u03b2-catenin through mechanisms involving FRAT1 and PAK4","volume":"127","author":"Jin","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0275","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0280","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymeth.2015.01.003","article-title":"Methods to study chaperone-mediated autophagy","volume":"75","author":"Patel","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0285","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1074\/jbc.M112.414771","article-title":"Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation","volume":"288","author":"Hubbi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0290","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbamcr.2008.05.016","article-title":"The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets","volume":"1783","author":"Kovacevic","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2019.02.008_bb0295","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0300","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1158\/0008-5472.CAN-08-1047","article-title":"Development of a small-molecule serum-and glucocorticoid-regulated kinase-1 antagonist and its evaluation as a prostate cancer therapeutic","volume":"68","author":"Sherk","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0305","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41419-018-0309-3","article-title":"Glycogen synthase kinase-3\u03b2 inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2019.02.008_bb0310","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1083\/jcb.200106056","article-title":"Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies","volume":"156","author":"Longva","year":"2002","journal-title":"J. Cell Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919300602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443919300602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:48:17Z","timestamp":1760417297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443919300602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0925443919300602"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.008","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}